T. Ian Clark's most recent trade in GoodRx Holdings Inc - Ordinary Shares - Class A was a trade of 17,248 Restricted Stock Unit done . Disclosure was reported to the exchange on July 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GoodRx Holdings Inc - Ordi... | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2025 | 17,248 | 34,497 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc - Ordi... | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.74 per share. | 08 Jul 2025 | 17,248 | 100,150 | - | 4.7 | 81,756 | Class A Common Stock |
| Guardant Health Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 6,833 | 6,833 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 48.38 per share. | 17 Jun 2025 | 6,672 | 9,851 (0%) | 0% | 48.4 | 322,819 | Common Stock |
| Guardant Health Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 5,092 | 5,092 | - | - | Restricted Stock Units | |
| Corvus Pharmaceuticals Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 8,088 | 16,523 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 8,088 | 0 | - | - | Restricted Stock Units | |
| Olema Pharmaceuticals Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 24,150 | 24,150 | - | - | Stock Option (right to buy) | |
| GoodRx Holdings Inc - Ordi... | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 57,050 | 82,902 | - | 0 | Class A Common Stock | |
| Kyverna Therapeutics Inc. | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 65,351 | 65,351 | - | - | Stock Option (right to buy) | |
| Kyverna Therapeutics Inc. | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 16,634 | 16,634 | - | 0 | Common Stock | |
| Altria Group | Ian L.T. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 3,219 | 15,094 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Ian T. Clark | Director | Other type of transaction at price $ 0.00 per share. | 12 Nov 2024 | 8,435 | 0 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Ian T. Clark | Director | Other type of transaction at price $ 0.00 per share. | 12 Nov 2024 | 8,435 | 8,435 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 29.44 per share. | 12 Nov 2024 | 7,242 | 8,435 (0%) | 0% | 29.4 | 213,169 | Common Stock |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2024 | 1,076 | 0 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 12 Nov 2024 | 1,076 | 16,753 (0%) | 0% | 4.2 | 4,498 | Common Stock |
| Guardant Health Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 29.52 per share. | 12 Nov 2024 | 1,076 | 15,677 (0%) | 0% | 29.5 | 31,761 | Common Stock |
| GoodRx Holdings Inc - Ordi... | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 51,745 | 51,745 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc - Ordi... | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 25,852 | 25,852 | - | 0 | Class A Common Stock | |
| Olema Pharmaceuticals Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option (right to buy) | |
| Corvus Pharmaceuticals Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 10,703 | 10,703 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 8,088 | 8,088 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 6,776 | 15,677 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 6,776 | 0 | - | - | Restricted Stock Units | |
| Altria Group | Ian L.T. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 3,800 | 11,225 (0%) | 0% | 0 | Common Stock | |
| Corvus Pharmaceuticals Inc | T. Ian Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Altria Group | Ian L.T. Clarke | Director | Purchase of securities on an exchange or from another person at price $ 40.57 per share. | 06 Nov 2023 | 1,100 | 7,145 (0%) | 0% | 40.6 | 44,625 | Common Stock |
| Olema Pharmaceuticals Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Corvus Pharmaceuticals Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 8,803 | 8,803 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 6,776 | 6,776 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2023 | 6,703 | 8,901 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2023 | 6,703 | 0 | - | - | RESTRICTED STOCK UNITS | |
| Tectonic Therapeutic Inc. | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 17,643 | 17,643 | - | - | Stock Option (Right to Buy) | |
| Altria Group | Ian L.T. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 3,901 | 5,964 (0%) | 0% | 0 | Common Stock | |
| Corvus Pharmaceuticals Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Corvus Pharmaceuticals Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 8,789 | 8,789 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 6,703 | 6,703 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 2,198 | 0 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 2,198 | 2,198 (0%) | 0% | 0 | COMMON STOCK | |
| Tectonic Therapeutic Inc. | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Agios Pharmaceuticals Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2022 | 1,585 | 0 | - | - | Restricted stock unit | |
| Agios Pharmaceuticals Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2022 | 1,585 | 6,549 (0%) | 0% | 0 | Common stock | |
| Altria Group | Ian L.T. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 3,372 | 3,372 (0%) | 0% | 0 | Common Stock | |
| Altria Group | Ian L.T. Clarke | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.90 per share. | 19 May 2022 | 1,309 | 2,063 (0%) | 0% | 51.9 | 67,937 | Common Stock |
| Corvus Pharmaceuticals Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 1,076 | 1,076 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 130.00 per share. | 01 Sep 2021 | 1,076 | 0 (0%) | 0% | 130 | 139,880 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 01 Sep 2021 | 1,076 | 1,076 (0%) | 0% | 4.2 | 4,498 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 130.00 per share. | 29 Jun 2021 | 10,559 | 0 (0%) | 0% | 130 | 1,372,670 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.09 per share. | 29 Jun 2021 | 4,840 | 10,559 (0%) | 0% | 77.1 | 373,116 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2021 | 4,840 | 0 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2021 | 1,076 | 2,152 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 29 Jun 2021 | 1,076 | 5,719 (0%) | 0% | 4.2 | 4,498 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 3,135 | 3,135 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 2,198 | 2,198 | - | - | RESTRICTED STOCK UNITS | |
| Tectonic Therapeutic Inc. | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 17,438 | 17,438 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Agios Pharmaceuticals Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2021 | 1,686 | 4,964 (0%) | 0% | 0 | Common stock | |
| Agios Pharmaceuticals Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2021 | 1,686 | 0 | - | - | Restricted stock units | |
| Agios Pharmaceuticals Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 8,888 | 8,888 | - | - | Stock options (right to buy) | |
| Agios Pharmaceuticals Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 1,585 | 1,585 | - | - | Restricted stock unit | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2021 | 538 | 3,228 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 159.92 per share. | 26 Apr 2021 | 538 | 4,643 (0%) | 0% | 159.9 | 86,037 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 26 Apr 2021 | 538 | 5,181 (0%) | 0% | 4.2 | 2,249 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2021 | 538 | 3,766 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 25 Mar 2021 | 538 | 5,181 (0%) | 0% | 4.2 | 2,249 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 132.09 per share. | 25 Mar 2021 | 538 | 4,643 (0%) | 0% | 132.1 | 71,064 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 154.00 per share. | 25 Feb 2021 | 538 | 4,643 (0%) | 0% | 154 | 82,852 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 25 Feb 2021 | 538 | 5,181 (0%) | 0% | 4.2 | 2,249 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2021 | 538 | 4,304 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 538 | 4,842 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 162.00 per share. | 25 Jan 2021 | 538 | 4,643 (0%) | 0% | 162 | 87,156 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 25 Jan 2021 | 538 | 5,181 (0%) | 0% | 4.2 | 2,249 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 04 Jan 2021 | 2,690 | 7,333 (0%) | 0% | 4.2 | 11,244 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 2,690 | 0 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 129.23 per share. | 04 Jan 2021 | 2,690 | 4,643 (0%) | 0% | 129.2 | 347,629 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2020 | 538 | 5,380 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 135.00 per share. | 28 Dec 2020 | 538 | 4,643 (0%) | 0% | 135 | 72,630 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 28 Dec 2020 | 538 | 5,181 (0%) | 0% | 4.2 | 2,249 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 03 Dec 2020 | 2,690 | 4,643 (0%) | 0% | 120 | 322,800 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2020 | 2,690 | 2,690 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 03 Dec 2020 | 2,690 | 7,333 (0%) | 0% | 4.2 | 11,244 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 113.28 per share. | 25 Nov 2020 | 538 | 4,643 (0%) | 0% | 113.3 | 60,945 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2020 | 538 | 5,918 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 25 Nov 2020 | 538 | 5,181 (0%) | 0% | 4.2 | 2,249 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 105.28 per share. | 03 Nov 2020 | 2,690 | 4,643 (0%) | 0% | 105.3 | 283,203 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 2,690 | 5,380 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 03 Nov 2020 | 2,690 | 7,333 (0%) | 0% | 4.2 | 11,244 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 104.03 per share. | 26 Oct 2020 | 538 | 4,643 (0%) | 0% | 104.0 | 55,968 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Oct 2020 | 538 | 6,456 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 26 Oct 2020 | 538 | 5,181 (0%) | 0% | 4.2 | 2,249 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2020 | 2,690 | 8,070 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Ian T. Clark | Director | Sale of securities on an exchange or to another person at price $ 108.50 per share. | 25 Sep 2020 | 2,690 | 4,643 (0%) | 0% | 108.5 | 291,865 | COMMON STOCK |
| Guardant Health Inc | Ian T. Clark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 25 Sep 2020 | 2,690 | 7,333 (0%) | 0% | 4.2 | 11,244 | COMMON STOCK |